Medsider Radio: Learn From Proven Medtech And Healthcare Experts

This interview brings us to the end of a throwback mini-series that I’ve been releasing over the past few months with some of my favorite Medsider guests of all time.On this particular episode, I chatted with Rich Ferrari, Managing Director of De Novo Ventures, and one of the most well-known VC’s in the medtech space. Here are some of the points we covered: Novel ways to fund early-stage medical device companies. The metrics that are most important when it comes to early-stage versus late-stage medtech investing. Why does the FDA “runway” seem to get longer and longer over time? How Rich identifies and validates whether an idea is truly disruptive. Download the transcript here.